Malignant Mesothelioma, Hypoalbuminaemia and the Effect of Carboplatin/Pemetrexed on Survival

The incidence of mesothelioma is increasing. Adverse prognostic factors include non-epithelioid histology, performance status and hypoalbuminaemia. Overall survival has not improved significantly, but treatment with carboplatin/pemetrexed chemotherapy is associated with a significant survival benefit.